These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21176009)

  • 1. Clinical perspective: biomarkers in pulmonary arterial hypertension.
    Heresi GA
    Int J Clin Pract Suppl; 2011 Jan; (169):5-7. PubMed ID: 21176009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension: evaluation of the newly diagnosed patient.
    Torbicki A; Kurzyna M
    Semin Respir Crit Care Med; 2005 Aug; 26(4):372-8. PubMed ID: 16121313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in pulmonary arterial hypertension.
    Rafeq S; Shah AM; Preston IR
    Int J Clin Pract Suppl; 2009 Sep; (162):36-41. PubMed ID: 19624798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seven years of experience in patients with pulmonary arterial hypertension in Ege University Hospital: diagnostic approach of a single center].
    Kayikçioğlu M; Kültürsay H
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):279-85. PubMed ID: 18676304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of biomarkers in pulmonary arterial hypertension.
    Cracowski JL; Leuchte HH
    Am J Cardiol; 2012 Sep; 110(6 Suppl):32S-38S. PubMed ID: 22921030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise as an end-point in pulmonary hypertension trials.
    McCullagh B; Girgis RE
    Int J Clin Pract Suppl; 2010 Jan; (165):4-6. PubMed ID: 19958394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical treatment of pulmonary arterial hypertension.
    Adamali H; Gaine SP; Rubin LJ
    Semin Respir Crit Care Med; 2009 Aug; 30(4):484-92. PubMed ID: 19634087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostics in pulmonary hypertension.
    Schannwell CM; Steiner S; Strauer BE
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):591-602. PubMed ID: 18204173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary hypertension: biomarkers.
    Rhodes CJ; Wharton J; Wilkins MR
    Handb Exp Pharmacol; 2013; 218():77-103. PubMed ID: 24092337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel serum biomarkers in pulmonary arterial hypertension.
    McGlinchey N; Johnson MK
    Biomark Med; 2014; 8(8):1001-11. PubMed ID: 25343672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endpoints in pulmonary arterial hypertension: the role of clinical worsening.
    Peacock A; Keogh A; Humbert M
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S1-9. PubMed ID: 20375659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment.
    Distler O; Pignone A
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv22-5. PubMed ID: 16980719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
    Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
    J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical end-points and surrogate markers of pulmonary arterial hypertension in the light of evidence-based treatment].
    Can MM; Kaymaz C
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():36-42. PubMed ID: 20819765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of pulmonary hypertension].
    Natali D; Simonneau G; Humbert M; Montani D
    Rev Pneumol Clin; 2008 Jun; 64(3):151-61. PubMed ID: 18656791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surrogate end points for pulmonary arterial hypertension.
    Kawut SM; Palevsky HI
    Am Heart J; 2004 Oct; 148(4):559-65. PubMed ID: 15459583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of outcome measures in pulmonary hypertension clinical trials.
    Parikh KS; Rajagopal S; Arges K; Ahmad T; Sivak J; Kaul P; Shah SH; Tapson V; Velazquez EJ; Douglas PS; Samad Z
    Am Heart J; 2015 Sep; 170(3):419-29.e3. PubMed ID: 26385024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspective on the optimal endpoints for pulmonary arterial hypertension trials.
    Rubin L; Simonneau G
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S43-6. PubMed ID: 20375664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment algorithm for pulmonary arterial hypertension].
    Hoeper MM
    Herz; 2005 Jun; 30(4):326-31. PubMed ID: 15965810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.